Clinpathfinder helps healthcare and life science teams identify opportunities, assess them faster, and make more confident strategic decisions. We bridge fragmented data, structured analysis, and precise execution.
We translate fragmented clinical data, market trends, and regulatory mandates into prioritized frameworks for immediate strategic action.
Monitor global biotech pipelines, clinical trial progress, and FDA/EMA regulatory milestones to identify prime in-licensing opportunities and rare disease targets.
Output: Deal Structuring & BD
Our KOL Connect platform maps global physician influence, clinical trial history, and publication networks. We transition life sciences BD from relationship-based guesswork to data-backed execution.
Output: Target & Partner Evaluation
Utilize generative AI trained on tens of thousands of FDA protocols to automate study designs, regulatory filings, and patient screening criteria.
Output: Reduced R&D Timelines
Generic search platforms provide noisy volume; traditional consulting provides static reports. Clinpathfinder provides a dynamic, structured intelligence layer built specifically for the complexities of the US healthcare market, powered by global engineering leverage.
Frameworks structured around FDA standards, CPT coding, and clinical pathways, not generic algorithms.
"Trust Proxy" architecture ensuring zero PHI leaves the US. Strict HIPAA alignment and data residency controls.
| Capability | Generic Tools / Manual | Clinpathfinder |
|---|---|---|
| Data Relevancy | High volume, noisy | Curated, clinically validated |
| Output Format | Unstructured text / raw lists | Decision-ready frameworks |
| System Integration | Requires "Rip & Replace" | Plug-in productivity layer |
| Speed to Action | Months of synthesis | Automated prioritization |
We don't replace your systems of record; we empower them. Our platform serves as the bridge between raw data sources and your strategic actions.
Real-world commercial relevance across the life sciences and provider ecosystems.
Problem: Identifying qualified Principal Investigators (PIs) is slow and reliant on fragmented, relationship-based networks.
Solution: Access structured profiles of clinical experts mapped by trial history, global publications, and influence metrics.
Problem: Navigating complex regulatory timelines, exclusivity windows, and licensing opportunities across fragmented global databases.
Solution: AI-driven scans of FDA/EMA databases to predict approval timelines and identify prime rare disease assets.
Problem: Manual clinical trial protocol design creates massive operational bottlenecks and exorbitant medical writing costs.
Solution: Generative AI trained on FDA guidelines to accelerate compliant study design and documentation.
Problem: Expanding into new indications requires deep understanding of fluid reimbursement and competitive landscapes.
Solution: Systematic evaluation of market access dynamics to confidently prioritize highest-value commercial pathways.
Problem: International health-tech innovators face blind spots regarding US clinical practices and local stakeholder mapping.
Solution: Bridge the data gap with structured intelligence on US clinical pathways and influential medical centers.
Need a specialized framework for your organization?
Let's discuss your requirements →A pharmaceutical company expanding into a new oncology indication lacked internal data infrastructure to efficiently map regional physician influence and clinical trial capacity.
Integrated Clinpathfinder's KOL Connect platform to aggregate publication data, past trial involvement, and peer-to-peer influence networks.
Transitioned from relationship-based scouting to data-driven filtering. Identified and prioritized the top 50 viable trial sites within 2 weeks, significantly accelerating study initiation.
A biopharma company needed to identify and evaluate early-stage orphan drug candidates for in-licensing but struggled with fragmented trial and regulatory data.
Utilized Clinpathfinder's Regulatory Intelligence engine to cross-reference ClinicalTrials.gov, FDA Orphan designations, and deal comparables.
Highlighted three high-probability targets with clear regulatory exclusivity windows, allowing the BD team to initiate successful licensing negotiations months ahead of competitors.
Rapid 90-day validation programs to test our Copilot or KOL data within your specific environment before scaling.
Predictable monthly recurring models for our Copilot and Compliance Shield tools, designed for clinics and agencies.
Data-driven intelligence projects for biotech BD teams evaluating new targets, market access, or clinical landscapes.
Headless infrastructure integrations for digital health startups needing rapid, compliant clinical capabilities.
Our "Trust Proxy" architecture ensures that while you benefit from high-velocity engineering innovation, strict data residency and compliance protocols remain securely managed within the United States.
Stop navigating clinical and commercial complexities with fragmented tools. Partner with Clinpathfinder to structure your intelligence and execute your next strategic move.